NPI: 1497977714 · NORTH LITTLE ROCK, AR 72117 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/03/2007
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/03/2007 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,183 | $123K |
| 2019 | 14,812 | $124K |
| 2020 | 16,852 | $151K |
| 2021 | 12,197 | $111K |
| 2022 | 6,292 | $98K |
| 2023 | 4,688 | $66K |
| 2024 | 2,628 | $51K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 23,709 | 1,738 | $250K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 26,491 | 1,363 | $195K |
| 83970 | 804 | 646 | $98K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,739 | 1,182 | $49K |
| 82728 | 398 | 332 | $34K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 127 | 111 | $24K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 441 | 207 | $17K |
| 83550 | 403 | 332 | $14K | |
| 83540 | 403 | 332 | $13K | |
| 82108 | 64 | 47 | $11K | |
| A4657 | Syringe, with or without needle, each | 1,256 | 942 | $9K |
| 85041 | 762 | 643 | $4K | |
| 85048 | 742 | 626 | $2K | |
| G0008 | Administration of influenza virus vaccine | 26 | 25 | $1K |
| 82746 | 53 | 45 | $225.76 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 120 | 52 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 47 | 29 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 3,033 | 622 | $0.00 |
| 85045 | 34 | 28 | $0.00 |